MAPI Research Trust provides reliable, comprehensive and up-to-date information services to research scientists, pharmaceutical companies, and governmental health agencies involved in the fields of Patient-Reported Outcomes (PRO) and Pharmaco-Epidemiology worldwide.
Home SERVICES Questionnaire Licensing
HAQ (Health Assessment Questionnaire) PDF Print E-mail
 
Developed by:
James F. Fries (USA)

Objective:
To assess the difficulty in performing activities of daily living (originally designed for adult arthritics, it has been used in a wide range of research settings)

Copyright:
University of Stanford, USA

Reference publication:
Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23:137-45

Useful information:
There are different versions of the HAQ : the full HAQ, the HAQ-DI, the PROMIS-HAQ and the HAQ version that MAPI Research Trust distributes.

The full HAQ and the HAQ-DI are available directly from the ARAMIS website.

The HAQ version distributed by MAPI Research Trust is the one that was published in the following article: Fries JF. The assessment of disability: from first to future principles. Br J Rheumatol . 1983 Aug;22(3 Suppl):48-58.

This HAQ version corresponds to the disability section + VAS pain scale of the full HAQ. Please note that all the translations distributed by MAPI Research Trust are based on this version.

Please note that it is recommended to use the PROMIS-HAQ for any future studies. For any information about how to have the HAQ existing translations in line with the PROMIS-HAQ, please contact us at: This e-mail address is being protected from spambots. You need JavaScript enabled to view it .

Conditions of use:

1. User Agreement:

User is required to complete and sign a User Agreement in which specific conditions requested by the Author are detailed.

2. Access fees:

 Distribution fees are requested according to the study design and context of use of the questionnaire:

- In not-funded academic research (1) and individual clinical practice: free of charge
- In funded academic research (2): 300 €* per study + 50 €* per language version
- In commercial studies (3) involving "for-profit" organizations: 500 €* per study + 150 €* per language 
  version

* excluding VAT

(1) Not funded academic research: if the project is not explicitly funded, but funding comes from overall departmental funds or from the University or individual funds then fees are waived.

(2) Funded academic research: projects receiving funding from commerce, government, EU should anticipate paying the corresponding fees.

(3) Commercial studies (industry, CRO, any for-profit companies)

Contact information:

MAPI Research Trust
Christelle Berne

27 rue de la Villette
F - 69003 LYON
Tel: +33 4 72 13 65 75
Fax: +33 4 72 13 66 82
This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Please have the User Agreement completed, dated and signed and return one original copy to MAPI Research Trust by post. As soon as we receive it, we will process your request.

More information on HAQ on PROQOLID and on the ARAMIS website.

[ BACK ]
 

New questionnaires distributed by MAPI Research Trust

ADCPQ (Alzheimer’s Disease Caregiver Preference Questionnaire)  
Novartis Pharmaceuticals Corporation (USA)

FIS (Fatigue Impact Scale)
D-FIS (Daily Fatigue Impact Scale)
John Fisk (Canada)  

HIV-SQUAD (Symptom Quality of Life Adherence) Questionnaire ®
Abbott France (France) 

MOS-HIV (Medical Outcome Study-HIV Health Survey)
Albert Wu (USA)

MPQ (McGill Pain Questionnaire)
Ronald Melzack (Canada)

MPQ-SF (McGill Pain Questionnaire - Short Form)
Ronald Melzack (Canada)

Nausea Questionnaire 
Ronald Melzack (Canada)

ODI (Oswestry Disability Questionnaire)
Jeremy Fairbank (UK)

PHQ (Patient Health Questionnaire Screeners
Pfizer Inc. (USA)

PRAC-Test (PRAgmatic Content and face validity Test)
Mapi Values (France)

SF-MPQ-2 (Short-form McGill Pain Questionnaire)
Ronald Melzack (Canada) and IMMPACT (USA) 


To access our catalog, please click here.



Coming soon!

Crohn and Anti-tnf Treatment Satisfaction questionnaire
Abbott France (France)


For any information, please contact:
contact@mapi-trust.org